Dr. Lal Path Labs Stock Screener | Share Price & Fundamental Analysis
LALPATHLAB
Healthcare Service Provider
Screen Dr. Lal Path Labs share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1502.10
▲
27.90 (1.89%)
Share Price BSE
₹1502.25
▲
29.30 (1.99%)
Market Cap
₹25,139.36 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.40
EPS (TTM)
₹58.48
Dividend Yield
0.81%
Debt to Equity
0.10
52W High
₹3450.90
52W Low
₹1391.60
Operating Margin
28.00%
Profit Margin
24.84%
Revenue (TTM)
₹628.00
EBITDA
₹195.00
Net Income
₹156.00
Total Assets
₹2,717.00
Total Equity
₹2,207.00
Dr. Lal Path Labs Share Price History - Stock Screener Chart
Screen LALPATHLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Dr. Lal Path Labs Company Profile - Fundamental Screener
Screen Dr. Lal Path Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for LALPATHLAB shares.
Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371 clinical laboratories, 5,102 patient service centers, and 10,938 pickup points as of March 31, 2023. The company provides services to individual patients, hospitals, healthcare providers, and corporate customers. Its test catalog includes 481 test panels, 2763 pathology tests, and 1947 radiology and cardiology tests. Dr Lal PathLabs has expanded through acquisitions and has several domestic and international subsidiaries. The company continues to grow its network and enhance its technological capabilities to improve its diagnostic services.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Arvind Lal
ISIN
INE600L01024
Website
https://www.lalpathlabs.com
Dr. Lal Path Labs Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen LALPATHLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,717 | 2,456 | 2,386 | 2,353 | 1,661 | 1,374 | 1,091 | 916 | 764 | 625 |
| Current Assets | 1,364 | 1,127 | 973 | 875 | 1,145 | 893 | 814 | 623 | 511 | 424 |
| Fixed Assets | 1,168 | 1,228 | 1,305 | 1,375 | 447 | 413 | 209 | 208 | 190 | 166 |
| Liabilities | ||||||||||
| Total Liabilities | 2,717 | 2,456 | 2,386 | 2,353 | 1,661 | 1,374 | 1,091 | 916 | 764 | 625 |
| Current Liabilities | 108 | 105 | 216 | 310 | 111 | 93 | 1 | 8 | 28 | 24 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,207 | 1,885 | 1,700 | 1,544 | 1,276 | 1,054 | 951 | 792 | 662 | 510 |
| Share Capital | 84 | 84 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves & Surplus | 2,089 | 1,766 | 1,583 | 1,425 | 1,162 | 974 | 890 | 734 | 577 | 424 |
Screen LALPATHLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 628 | 698 | 755 | 564 | 623 | 682 | 622 | 505 | 555 | 619 | 557 | 498 | 511 | 543 | 500 |
| Expenses | 434 | 478 | 507 | 401 | 432 | 458 | 443 | 375 | 395 | 424 | 398 | 364 | 385 | 390 | 376 |
| EBITDA | 195 | 220 | 249 | 163 | 191 | 224 | 179 | 130 | 161 | 196 | 159 | 133 | 126 | 153 | 124 |
| Operating Profit % | 28.00% | 29.00% | 31.00% | 27.00% | 28.00% | 31.00% | 26.00% | 24.00% | 27.00% | 30.00% | 26.00% | 25.00% | 23.00% | 27.00% | 23.00% |
| Depreciation | 36 | 35 | 41 | 37 | 35 | 35 | 36 | 38 | 35 | 36 | 36 | 38 | 36 | 39 | 38 |
| Interest | 5 | 5 | 5 | 7 | 6 | 6 | 5 | 9 | 8 | 8 | 7 | 12 | 9 | 11 | 9 |
| Profit Before Tax | 153 | 181 | 204 | 120 | 150 | 183 | 138 | 83 | 118 | 152 | 116 | 84 | 81 | 103 | 77 |
| Tax | -2 | 47 | 51 | 34 | 42 | 52 | 40 | 26 | 34 | 42 | 34 | 21 | 23 | 30 | 23 |
| Net Profit | 156 | 134 | 152 | 86 | 108 | 131 | 98 | 57 | 84 | 111 | 82 | 62 | 58 | 72 | 54 |
| EPS | 18.57 | 15.88 | 18.05 | 10.13 | 12.79 | 15.52 | 11.60 | 6.84 | 9.95 | 13.16 | 9.77 | 7.41 | 6.97 | 8.64 | 6.37 |
Dr. Lal Path Labs Cash Flow Screener - Liquidity Fundamentals
Screen LALPATHLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 569 | 535 | 456 | 447 | 398 | 284 | 219 | 197 | 171 | 159 |
| Investing Activities | -303 | -24 | -287 | -449 | -212 | -26 | -100 | -172 | -137 | -164 |
| Financing Activities | -334 | -414 | -283 | 136 | -139 | -190 | -55 | 13 | -32 | 0 |
| Net Cash Flow | -68 | 97 | -115 | 134 | 48 | 67 | 64 | 37 | 2 | -5 |
Screen LALPATHLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.91% | 53.79% | 53.21% | 53.21% | 54.60% | 54.60% | 53.92% | 53.91% |
| FII Holding | 23.91% | 21.68% | 21.86% | 20.68% | 26.15% | 25.42% | 26.82% | 26.82% |
| DII Holding | 16.08% | 17.91% | 18.49% | 18.96% | 9.69% | 12.71% | 12.89% | 13.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 4.11% | 5.23% | 5.19% | 5.71% | 6.47% | 4.91% | 4.10% | 4.01% |
| Other Holding | 2.00% | 1.38% | 1.25% | 1.43% | 3.09% | 2.35% | 2.27% | 2.10% |
| Shareholder Count | 115,699 | 118,656 | 112,703 | 114,385 | 146,741 | 131,189 | 116,606 | 116,236 |
Dr. Lal Path Labs Dividend Screener - Share Yield Analysis
Screen LALPATHLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹24.00 | 1.62% |
| 2024-March | ₹24.00 | 1.94% |
| 2023-March | ₹12.00 | 1.06% |
| 2022-March | ₹12.00 | 1.31% |
| 2021-March | ₹20.00 | 1.53% |
| 2020-March | ₹12.00 | 0.89% |
| 2019-March | ₹6.00 | 0.86% |
| 2018-March | ₹4.50 | 0.86% |
| 2017-March | ₹3.00 | 0.68% |
Dr. Lal Path Labs Index Membership - Market Screener Classification
Screen LALPATHLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Dr. Lal Path Labs Market Events Screener - Corporate Actions
Screen LALPATHLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | 5.49% |
| 2025-12-19 | 2025-12-19 | Bonus | 1:1 | -3.25% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 7.00 /share | 0.60% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 0.59% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 6.00 /share | 3.08% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 2.72% |
| 2025-06-28 | 2025-06-28 | Annual General Meeting | NA | -0.61% |
| 2025-06-06 | 2025-06-06 | Dividend | ₹ 6.00 /share | 2.46% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | 2.73% |
| 2025-02-06 | 2025-02-06 | Extraordinary General Meeting | NA | 0.00% |
| 2025-02-05 | 2025-02-05 | Dividend | ₹ 6.00 /share | 2.56% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -2.95% |
| 2024-11-05 | 2024-11-05 | Dividend | ₹ 6.00 /share | -7.31% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -2.43% |
| 2024-08-20 | 2024-08-20 | Dividend | ₹ 6.00 /share | 4.47% |
Dr. Lal Path Labs Competitors Screener - Peer Comparison
Screen LALPATHLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 25,139 | 46.00 | 2,555 | 11.28% | 492 | 54.65 |
| Vijaya Diagnostic Centre | 10,735 | 71.76 | 700 | 23.06% | 144 | 64.28 |
| Metropolis Healthcare | 9,860 | 62.94 | 1,346 | 10.64% | 146 | 52.50 |
| Thyrocare Technologies | 7,172 | 56.03 | 702 | 20.80% | 91 | 47.93 |
| Nephrocare Health Services | 4,627 | 70.14 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,372 | 27.63 | 743 | 16.70% | 78 | 40.75 |
| Suraksha Diagnostic | 1,423 | 44.85 | 256 | 15.11% | 31 | 35.69 |
| One Global Service Provider | 1,235 | 28.22 | 148 | 134.60% | 19 | 60.12 |
| 3B BlackBio DX | 1,217 | 24.50 | 112 | 28.72% | 48 | 55.34 |
| Sastasundar Ventures | 952 | -103.74 | 1,171 | -18.47% | -134 | 38.51 |
Dr. Lal Path Labs Company Announcements - News Screener
Screen LALPATHLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2026-01-03 | Board Meeting Intimation for Notice Of Board Meeting | View |
| 2025-12-27 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-12-15 | Amended Trust Deed (ESOP) | View |
| 2025-12-12 | Intimation Of Record Date For The Purpose Of Issuing Bonus Equity Shares | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-12-08 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-01 | Receipt Of An Assessment Order And Demand Notice Issued By Income Tax Department | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-10-31 | Record Date For 2Nd Interim Dividend FY 2025-26 | View |
| 2025-10-31 | Introduction Of Dr. Lal Pathlabs Employee RSU 2025 (ESOP Scheme) | View |